However, much of the current literature that lends support for caveolin-1 serving as a tumour suppressor protein has been generated by the use of in vitro and ex vivo overexpression systems for caveolin-1 that are assumed to mimic the activity of endogenously expressed caveolin. This evidence concerns the gene CAV1 and neoplasm.